GLP-1 Medication Comparisons
Evidence-based comparisons to help you understand the differences between weight loss medications and choose the right option for your needs.
Find Your OptionQuick answer — semaglutide vs tirzepatide
Tirzepatide produces more weight loss on average per pivotal trials: ~22.5% body-weight reduction at 72 weeks on tirzepatide 15 mg (SURMOUNT-1, NEJM 2022) versus ~14.9% at 68 weeks on semaglutide 2.4 mg (STEP 1, NEJM 2021). Mechanism: tirzepatide is a dual GIP + GLP-1 receptor agonist; semaglutide is a single GLP-1 receptor agonist. Pricing through Trimi: $99/month for compounded semaglutide, $125/month for compounded tirzepatide on annual billing — all-inclusive (medication, US-licensed clinician via Beluga Health 50-state network, dose changes, free shipping). Same active ingredients (RxCUI 1991302 sema, 1928264 tirz) as FDA-approved Wegovy/Ozempic/Zepbound/Mounjaro. For the full provider pricing comparison, see our cheapest legal GLP-1 online cornerstone.
Head-to-Head Comparisons
Tirzepatide vs Semaglutide
Comprehensive comparison of the two leading GLP-1 medications
Tirzepatide vs Semaglutide: 2025 Updates
Latest 2025 research and clinical data comparison
How to Switch from Semaglutide to Tirzepatide Safely
Complete guide to safely transitioning between medications
Real-World GLP-1 Weight Loss Results: Clinical Studies
What real patients experience vs clinical trial data
Semaglutide Comparisons
Ozempic vs Wegovy vs Rybelsus
Understanding the different semaglutide brand names
Semaglutide vs Phentermine
GLP-1 vs traditional weight loss medication
Compounded vs Brand Name
Safety, efficacy, and cost differences
2026 Comparisons & Provider Reviews
In-depth comparisons updated for 2026, including provider-by-provider GLP-1 platform reviews with verified pricing, regulatory status, and citation-grade clinical evidence.
Need Help Choosing?
Get personalized recommendations based on your health profile and goals.